D-0083-2018 Class II Terminated

Recalled by United Therapeutics Corp. — Durham, NC

FDA drug recall D-0083-2018 was initiated by United Therapeutics Corp. on Sep 11, 2017 and is designated Class II. Reason for recall: CGMP Deviations The recall status is terminated (terminated Apr 3, 2019). Affected quantity: 12 devices.

Recall details

Product Type
Drugs
Report Date
Nov 29, 2017
Initiation Date
Sep 11, 2017
Termination Date
Apr 3, 2019
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
12 devices

Product description

TYVASO (treprostinil) Inhalation Solution Treprostinil 1.74 mg/2.9 mL (0.6 mg/mL) Tyvaso Inhalation System Starter Kit Model# TD-100/A, Rx Only, Manufactured by United Therapeutics Corporation Research Triangle Park, NC 27709, NDC# 6630220601

Reason for recall

CGMP Deviations

Distribution pattern

PA

Code information

Lot #: 2101152; Exp. 12/11/2017 Lot #: 2101195; Exp. 04/26/2019

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0083-2018
openFDA file date
Nov 16, 2026
Loaded by RegDataLab
Nov 17, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0083-2018. Report a data issue: hello@regdatalab.com.